Provided by Tiger Trade Technology Pte. Ltd.

DORSAVI LTD

0.035
+0.0012.94%
Volume:8.51K
Turnover:294.00
Market Cap:39.39M
PE:-15.92
High:0.035
Open:0.034
Low:0.034
Close:0.034
52wk High:0.069
52wk Low:0.006
Shares:1.13B
Float Shares:445.86M
Volume Ratio:0.02
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.002
EPS(LYR):-0.002
ROE:-78.66%
ROA:-38.19%
PB:13.89
PE(LYR):-15.92

Loading ...

DorsaVi Ltd-Collaboration With Leading Tier 1 Taiwan Research Institute

THOMSON REUTERS
·
Jan 28

BRIEF-Dorsavi Seeks Trading Halt Pending RRAM Technology Agreement Announcement

Reuters
·
Jan 23

DorsaVi - Seeks Trading Halt Pending Rram Technology Agreement Announcement

THOMSON REUTERS
·
Jan 23

dorsaVi Acquires Portfolio of Human Brain-Inspired Computing Technology; Shares Jump 8%

MT Newswires Live
·
Nov 12, 2025

BUZZ-Australia's dorsaVi climbs to 1-month high on portfolio acquisition

Reuters
·
Nov 12, 2025

DorsaVi Ltd-DorsaVi Acquires Leading Process-in-Memory Neuromorphic Ip

THOMSON REUTERS
·
Nov 12, 2025

BRIEF-dorsaVi Seeks Trading Halt

Reuters
·
Nov 11, 2025

DorsaVi Ltd-Trading Halt

THOMSON REUTERS
·
Nov 11, 2025

dorsaVi Marks Mathew Regan's Commencement as Group CEO; Shares Fall 4%

MT Newswires Live
·
Nov 03, 2025

DorsaVi Ltd-Mathew Regan Commences as Group CEO & Office Address Change

THOMSON REUTERS
·
Nov 03, 2025

dorsaVi Engages With Potential Development Partners to Scale Down Resistive Random-Access Memory Technology

MT Newswires Live
·
Oct 29, 2025

DorsaVi Ltd-Quarterly Activities/Appendix 4C Cash Flow Report

THOMSON REUTERS
·
Oct 28, 2025

dorsaVi’s RRAM Reflex Platform Achieves Breakthrough in Robotic Speed and Intelligence

Small Caps
·
Oct 01, 2025

dorsaVi Says Reflex Platform Engineering Validation Confirms Potential for Biological-Grade Reflexes, Shares Jump Over 4%

MT Newswires Live
·
Sep 17, 2025

BUZZ-Australia's dorsaVi at near 5-year high on US distribution deal

Reuters
·
Sep 10, 2025

BRIEF-dorsaVi Signs Multi-Year Sales Agreement With Select Medical

Reuters
·
Sep 10, 2025

DorsaVi Ltd - Signs Multi-Year Sales Agreement With Select Medical

THOMSON REUTERS
·
Sep 10, 2025

DorsaVi Ltd - Deal to Offer Purchasing Options for Its FDA Approved Products Across Co's National Network

THOMSON REUTERS
·
Sep 10, 2025

dorsaVi Names Mathew Regan as CEO

MT Newswires Live
·
Aug 28, 2025

BRIEF-Dorsavi Appoints Mathew Regan As Group CEO

Reuters
·
Aug 28, 2025